Monitoramento sorológico de uma infecção toxoplásmica após transplante de células progenitoras hematopoiéticas

We report a primary response to Toxoplasma gondii following a hematopoietic stem cell transplantation in a patient with multiple myeloma. The primary response to T. gondii was supported by IgM, IgG and IgA seroconversion. The patient was promptly treated and there were no complications related to toxoplasmosis in the subsequent months.Esse relato de caso descreve uma resposta primária ao Toxoplasma gondii após transplante de células progenitoras hematopoiéticas em paciente com mieloma múltiplo. A resposta primária para o T. gondii foi evidenciada pela soroconversão observada na resposta de anticorpos IgM, IgG e IgA. O paciente foi prontamente tratado e complicações relacionadas à toxoplasmose não foram observadas nos meses subseqüentes

Serological Monitoring Of A Toxoplasma Infection After Hematopoietic Stem Cell Transplantation.

We report a primary response to Toxoplasma gondii following a hematopoietic stem cell transplantation in a patient with multiple myeloma. The primary response to T. gondii was supported by IgM, IgG and IgA seroconversion. The patient was promptly treated and there were no complications related to toxoplasmosis in the subsequent months.52225-

Association Of Postalimentary Lipemia With Atherosclerotic Manifestations.

We identified different lipemic and metabolic responses after the ingestion of a standardized meal by healthy adults and related them to atherosclerotic markers. Samples from 60 normolipidemic adults were collected before and after a liquid meal (40 g fat/m² body surface) at 0, 2, 4, 6, and 8 h for measurements of lipids, free fatty acids (FFA), insulin, cholesteryl ester transfer protein (CETP), autoantibodies to epitopes of oxidized LDL (oxLDL Ab), lipolytic activities, and apolipoprotein E polymorphism. Mean carotid intima-media thickness (cIMT) was determined by Doppler ultrasound. The volunteers were classified into early (N = 39) and late (N = 31) triacylglycerol (TAG) responders to the test meal. Late responders showed lower HDL cholesterol concentration at fasting and in the TAG peak, lower insulin and higher FFA concentrations compared to early responders. Multivariate regression analyses showed that mean cIMT was associated with gender (male) and age in early responders and by cholesterol levels at the 6th hour in late responders. oxLDL Ab were explained by lipoprotein lipase and negatively by hepatic lipase and oxLDL Ab (fasting period) by CETP (negative) and FFA (positive). This study is the first to identify a postalimentary insulin resistance state, combined with a reduced CETP response exclusively among late responders, and the identification of the regulators of postalimentary atherogenicity. Further research is required to determine the metabolic mechanisms described in the different postalimentary phenotypes observed in this study, as well as in different pathological states, as currently investigated in our laboratory.451086-9

Association of postalimentary lipemia with atherosclerotic manifestations

We identified different lipemic and metabolic responses after the ingestion of a standardized meal by healthy adults and related them to atherosclerotic markers. Samples from 60 normolipidemic adults were collected before and after a liquid meal (40 g fat/m² body surface) at 0, 2, 4, 6, and 8 h for measurements of lipids, free fatty acids (FFA), insulin, cholesteryl ester transfer protein (CETP), autoantibodies to epitopes of oxidized LDL (oxLDL Ab), lipolytic activities, and apolipoprotein E polymorphism. Mean carotid intima-media thickness (cIMT) was determined by Doppler ultrasound. The volunteers were classified into early (N = 39) and late (N = 31) triacylglycerol (TAG) responders to the test meal. Late responders showed lower HDL cholesterol concentration at fasting and in the TAG peak, lower insulin and higher FFA concentrations compared to early responders. Multivariate regression analyses showed that mean cIMT was associated with gender (male) and age in early responders and by cholesterol levels at the 6th hour in late responders. oxLDL Ab were explained by lipoprotein lipase and negatively by hepatic lipase and oxLDL Ab (fasting period) by CETP (negative) and FFA (positive). This study is the first to identify a postalimentary insulin resistance state, combined with a reduced CETP response exclusively among late responders, and the identification of the regulators of postalimentary atherogenicity. Further research is required to determine the metabolic mechanisms described in the different postalimentary phenotypes observed in this study, as well as in different pathological states, as currently investigated in our laboratory

Cytokine Production but Lack of Proliferation in Peripheral Blood Mononuclear Cells from Chronic Chagas' Disease Cardiomyopathy Patients in Response to T. cruzi Ribosomal P Proteins

Background:Trypanosoma cruzi ribosomal P proteins, P2β and P0, induce high levels of antibodies in patients with chronic Chagas' disease Cardiomyopathy (CCC). It is well known that these antibodies alter the beating rate of cardiomyocytes and provoke apoptosis by their interaction with β1-adrenergic and M2-muscarinic cardiac receptors. Based on these findings, we decided to study the cellular immune response to these proteins in CCC patients compared to non-infected individuals.Methodology/Principal findings:We evaluated proliferation, presence of surface activation markers and cytokine production in peripheral blood mononuclear cells (PBMC) stimulated with P2β, the C-terminal portion of P0 (CP0) proteins and T. cruzi lysate from CCC patients predominantly infected with TcVI lineage. PBMC from CCC patients cultured with P2β or CP0 proteins, failed to proliferate and express CD25 and HLA-DR on T cell populations. However, multiplex cytokine assays showed that these antigens triggered higher secretion of IL-10, TNF-α and GM-CSF by PBMC as well as both CD4+ and CD8+ T cells subsets of CCC subjects. Upon T. cruzi lysate stimulation, PBMC from CCC patients not only proliferated but also became activated within the context of Th1 response. Interestingly, T. cruzi lysate was also able to induce the secretion of GM-CSF by CD4+ or CD8+ T cells.Conclusions/Significance:Our results showed that although the lack of PBMC proliferation in CCC patients in response to ribosomal P proteins, the detection of IL-10, TNF-α and GM-CSF suggests that specific T cells could have both immunoregulatory and pro-inflammatory potential, which might modulate the immune response in Chagas' disease. Furthermore, it was possible to demonstrate for the first time that GM-CSF was produced by PBMC of CCC patients in response not only to recombinant ribosomal P proteins but also to parasite lysate, suggesting the value of this cytokine to evaluate T cells responses in T. cruzi infection.Fil: Longhi, Silvia Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: Atienza, Augusto. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaFil: Perez Prados, Graciela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; ArgentinaFil: Buying, Alcinette. Torrey Pines Institute for Molecular Studies; Estados UnidosFil: Balouz, Virginia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Buscaglia, Carlos Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Santos, Radleigh. Torrey Pines Institute for Molecular Studies; Estados UnidosFil: Tasso, Laura Mónica. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Bonato, Ricardo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaFil: Chiale, Pablo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaFil: Pinilla, Clemencia. Torrey Pines Institute for Molecular Studies; Estados UnidosFil: Judkowski, Valeria A.. Torrey Pines Institute for Molecular Studies; Estados UnidosFil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentin

Cyclooxygenase-2 and prostaglandin E<inf>2</inf> signaling through prostaglandin receptor EP- 2 favor the development of myocarditis during acute trypanosoma cruzi infection

Inflammation plays an important role in the pathophysiology of Chagas disease, caused by Trypanosoma cruzi. Prostanoids are regulators of homeostasis and inflammation and are produced mainly by myeloid cells, being cyclooxygenases, COX-1 and COX-2, the key enzymes in their biosynthesis from arachidonic acid (AA). Here, we have investigated the expression of enzymes involved in AA metabolism during T. cruzi infection. Our results show an increase in the expression of several of these enzymes in acute T. cruzi infected heart. Interestingly, COX-2 was expressed by CD68+ myeloid heart-infiltrating cells. In addition, infiltrating myeloid CD11b+Ly6G- cells purified from infected heart tissue express COX-2 and produce prostaglandin E2 (PGE2) ex vivo. T. cruzi infections in COX-2 or PGE2- dependent prostaglandin receptor EP-2 deficient mice indicate that both, COX-2 and EP-2 signaling contribute significantly to the heart leukocyte infiltration and to the release of chemokines and inflammatory cytokines in the heart of T. cruzi infected mice. In conclusion, COX-2 plays a detrimental role in acute Chagas disease myocarditis and points to COX-2 as a potential target for immune intervention.This work was supported by (NG) grants from “Fondo de Investigaciones Sanitarias” (PS09/00538 and PI12/00289); “Universidad Autónoma de Madrid” and “Comunidad de Madrid” (CC08-UAM/SAL-4440/08); by (MF) grants from “Ministerio de Ciencia e Innovación” (SAF2010-17833); “Red de Investigación de Centros de Enfermedades Tropicales” (RICET RD12/0018/0004); European Union (HEALTH-FE-2008-22303, ChagasEpiNet); AECID Cooperation with Argentine (A/025417/09 and A/031735/10), Comunidad de Madrid (S-2010/BMD- 2332) and “Fundación Ramón Areces”. NAG was recipient of a ISCIII Ph.D. fellowship financed by the Spanish “Ministerio de Sanidad”. CCM and HC were recipients of contracts from SAF2010-17833 and PI060388, respectively.Peer Reviewe

Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease

CD25High CD4+ regulatory T cells (Treg cells) have been described as key players in immune regulation, preventing infection-induced immune pathology and limiting collateral tissue damage caused by vigorous anti-parasite immune response. In this review, we summarize data obtained by the investigation of Treg cells in different clinical forms of Chagas' disease. Ex vivo immunophenotyping of whole blood, as well as after stimulation with Trypanosoma cruzi antigens, demonstrated that individuals in the indeterminate (IND) clinical form of the disease have a higher frequency of Treg cells, suggesting that an expansion of those cells could be beneficial, possibly by limiting strong cytotoxic activity and tissue damage. Additional analysis demonstrated an activated status of Treg cells based on low expression of CD62L and high expression of CD40L, CD69, and CD54 by cells from all chagasic patients after T. cruzi antigenic stimulation. Moreover, there was an increase in the frequency of the population of Foxp3+ CD25HighCD4+ cells that was also IL-10+ in the IND group, whereas in the cardiac (CARD) group, there was an increase in the percentage of Foxp3+ CD25High CD4+ cells that expressed CTLA-4. These data suggest that IL-10 produced by Treg cells is effective in controlling disease development in IND patients. However, in CARD patients, the same regulatory mechanism, mediated by IL-10 and CTLA-4 expression is unlikely to be sufficient to control the progression of the disease. These data suggest that Treg cells may play an important role in controlling the immune response in Chagas' disease and the balance between regulatory and effector T cells may be important for the progression and development of the disease. Additional detailed analysis of the mechanisms on how these cells are activated and exert their function will certainly give insights for the rational design of procedure to achieve the appropriate balance between protection and pathology during parasite infections

Insulin Secretion In Insulin Resistance States

Insulin secretion is regulated mainly by glucose stimulus changes and is characterized by first and second phase (biphasic time course). β-cell glucose sensitivity is essential to maintain glucose homeostasis and loss of that capacity has been related to progression from normal glucose tolerance to impaired glucose tolerance and diabetes mellitus. β-cell glucose sensitivity can be evaluated through a slope of dose-response curve which shows the ability to increase insulin release with the appropriate amount and time course to cope with acute changes in plasma glucose concentration. Some factors can modulate insulin secretion. One of them is glucose toxicity, the direct impairment of chronic hyperglycemia on β-cell function characterized as impairment in insulin response to glucose but not to other nonglucose secretagogues. A glucose-induced insulin secretion is completely restored if normoglycemia is achieved. Lipotoxicity is also related to lower glucose induced insulin secretion through different mechanisms. On the other hand, it is suggested that the incretin GLP-1 stimulates insulin secretion through increasing β-cell glucose sensitivity, inhibiting potassium channels and exacerbating the voltage-dependent calcium channels. Normoglycemia in states of insulin resistance is maintained by a compensatory increase in insulin secretion. Adipokines such as pro-inflammatory cytokines are related to insulin resistance in obesity and type 2 diabetes. The mechanisms underlying regulated-insulin secretion by adipokines and insulin resistance are very complex and not completely understood. In fact a real molecular and cellular inflammatory network takes place acting per se linking up lipotoxicity, glucotoxicity and insulin secretion. Adiponectin and weight loss, on the other hand, are related to the decrease in the pro-inflammatory state and improved insulin action and secretion. So the focus of this review is to address the mechanisms underlying reciprocal relationships between insulin secretion, insulin resistance and inflammation in the pathological state and in its subsequent improvement. © 2010 by Nova Science Publishers, Inc. All rights reserved.105128Caumo, A., Luzi, L., First-phase insulin secretion: does it exist in real life? Considerations on shape and function (2004) Am J Physiol Endocrinol Metab, 287, pp. E371-E385Brunzell, J.D., Robertson, R.P., Lerner, R.L., Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests (1976) J Clin Endocrinol Metab, 42, pp. 222-229Jones, C.N.O., Abbasi, F., Carantoni, M., Roles of insulin resistance and obesity in regulation of plasma insulin concentrations (2000) Am J Physiol, 278, pp. E501-508Weyer, C., Bogardus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794Abdul-Ghani, M.A., Tripathy, D., De Fronzo, R.A., Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose (2006) Diabetes Care, 29, pp. 1130-1139UK prospective diabetes study 7: Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (1990), 39 (9), pp. 905-912. , UKPDS Group. MetabolismSjöström, C.D., Lissner, L., Wedel, H., Sjöström, L., Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study (1999) Obes Res., 7, pp. 477-484Diabetes Prevention Program Research Group (2002) N Engl J Med., 346, pp. 393-403. , Reduction in the Incidence of Type2 Diabetes with Lifestyle Intervention or MetforminMuscelli, E., Mingrone, G., Camastra, S., Manco, M., Pereira, J.A., Pareja, J.C., Ferrannini, E., Differential effect of weight loss on insulin resistance in surgically treated obese patients (2005) Am J Med, 118 (1), pp. 51-57Cerasi, E., Luft, R., Efendic, S., Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study (1972) Diabetes, 21, pp. 224-234Malaisse, W.J., Sener, A., Herchuelz, A., Hutton, J.C., Insulin release: the fuel hypothesis (1979) Metabolism, 28, p. 373Levin, S.R., Karam, J.H., Hane, S., Enhancement of arginine-induced insulin secretion in man by prior administration of glucose (1971) Diabetes, 20, pp. 171-176Calles-Escandon, J., Robbins, D.C., Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose (1987) Diabetes, 36, pp. 1167-1172Cerasi, E., Luft, R., The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus (1967) Acta Endocrinol, 55, pp. 278-304Lefebre, P.J., Paolisso, G., Scheen, A.J., Henquin, J.C., Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications (1987) Diabetologia, 30, pp. 443-452Porksen, N., The in vivo regulation of pulsatile insulin secretion (2002) Diabetologia, 45, pp. 3-20Steiner, K.E., Mouton, S.M., Williams, P.E., Lacy, W.W., Cherrington, A.D., Relative importance of first and second-phase insulin secretion on glucose homeostasis in conscious dog (1986) Diabetes, 35, pp. 776-784Unger, R.H., Glucagon physiology and pathophysiology in the light of new advances (1985) Diabetologia, 28, pp. 574-578Nauck, M.A., Homberger, E., Eberhard, G.S., Allen, R.C., Eaton, R.P., Ebert, R., Creutzfeldt, W., Incretin effects oj increasing glucose loads in man calculated from venous insulin and c-peptide responses (1986) J Clin Endocrinol Metab, 63, pp. 492-498Kjems, L.L., Holst, J.J., Vølund, A., Madsbad, S., The influence of GLP-1 on glucose-stimulated insulin secretion. Effects on β-cell sensitivity in type 2 and nondiabetic subjects (2003) Diabetes, 52, pp. 380-386Gromada, J., Ding, W.G., Barg, S., Renstrom, E., Rorsman, P., Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors (1997) Pflugers Arch, 434, pp. 515-521Gromada, J., Bokvist, K., Ding, W.G., Holst, J.J., Nielsen, J.H., Rorsman, P., Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling (1998) Diabetes, 47, pp. 57-65Drucker, D.J., The role of gut hormones in glucose homeostasis (2007) J Clin Invesy, 117, pp. 24-32Drucker, D.J., The biology of incretin hormones (2006) Cell Metab, 3, pp. 153-165Holz, G.G., Habener, J.F., Signal transduction cross-talk in the endocrine system: pancreatic beta-cells and the glucose competence concept (1992) Trends Biochem Sci, 17, pp. 388-393Drucker, D.J., Biological actions and therapeutic potential of th glucagon-like peptide (2002) Gastroenterology, 122, pp. 531-544Brubaker, P.L., Drucker, D.J., Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1 and GLP-2 receptors (2002) Receptors Channels, 8, pp. 179-188Gerich, J.E., Oral hypoglycemic agents (1989) N Engl J Med, 321, pp. 1231-1245Drucker, D.J., Enhancing incretin action for the treatment of type 2 diabetes (2003) Diabetes Care, 26, pp. 2928-2940Perfetti, R., Merkel, P., Glucagon-like peptide-1: a major regulator of pancreatic-cell function (2000) Eur J Endocrinol, 143, pp. 717-725Cherrington, A.D., Edgerton, D., Sindelat, D.K., The direct and indirect effects of insulin on hepatic glucose production in vivo (1998) Diabetologia, 41, pp. 987-996Steiner, K.E., Mouton, S.M., Bowles, C.R., Williams, P.E., Cherrington, A.D., The relative importance of first and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog (1982) Diabetes, 31, pp. 964-972Toffolo, G., De Grandi, F., Cobelli, C., Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion (1995) Diabetes, 44, pp. 845-854Kahn, S.E., Prigeon, R.L., McCulloch, D.K., Boyko, E.J., Bergman, R.N., Schwartz, M.W., Neifing, J.L., Palmer, J.P., Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function (1993) Diabetes, 42, pp. 1663-1672Mari, A., Schmitz, O., Gastaldelli, A., Oestergaard, T., Nyholm, B., Ferrannini, E., Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects (2002) Am J Physiol Endocrinol Metab, 283, pp. E 1159-E 1166Ahrén, B., Pacini, G., Importance of quantifying insulinsecretion in relation to insulin sensitivity to accurately assess beta-cell function in clinical studies (2004) Eur J Endocrinol, 150, pp. 97-104Stumvoll, M., Tataranni, A., Stefan, N., Vozarova, B., Bogardus, C., Glucose allostasis (2003) Diabetes, 52, pp. 903-909Bergman, R.N., Ader, M., Huecking, K., Van Citters, G., Accurate assessment of beta-cell function: the hyperbolic correction (2002) Diabetes, 51 (SUPPL. 1), pp. s212-s220Mari, A., Ahrén, B., Pacini, G., Assessment of insulin secretion in relation to insulin resistance (2005) Curr Opin in Clin Nutr and Metab Care, 8, pp. 529-533Unwin, N., Shaw, J., Zimmet, P., Alberti, K.G.M.N., Impaired glucose tolerance and impaired fasting glicemia: the current satatus on definition and intervention (2002) Diabet Med, 19, pp. 708-723Buchanan, T.A., Xiang, A.H., Peters, R.K., Kjos, S.L., Marroquin, A., Goico, J., Ochoa, C., Azen, S.P., Preservation of pancreatic B cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women (2002) Diabetes, 51, pp. 2796-2803Ferrannini, E., Camastra, S., Gastaldelli, A., Sironi, A.M., Natali, A., Muscelli, E., Mingrone, G., Mari, A., Beta-Cell function in obesity. Effects of weight loss (2004) Diabetes, 53 (SUPPL. 3), pp. s26-s33Kitabchi, A.E., Temprosa, M., Knowler, W.C., Kahn, S.E., Fowler, S.E., Haffner, S.M., Andres, R., Shamoon, H., The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin (2005) Diabetes, 54, pp. 2404-2414Ahrén, B., Pacini, G., Impaired adaptation of first-phase insulin secretion in post-menopausal women with glucose intolerance (1997) Am J Physiol, 36, pp. E701-E707Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., De Fronzo, R.A., San Antonio Metabolism study: beta-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study (2004) Diabetologia, 47, pp. 31-39Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., De Fronzo, R.A., β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis (2005) J Clin Endocrinol Metab, 90 (1), pp. 493-500Efendic, S., Cerasi, E., Luft, R., Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in health, prediabetic, and diabetic subjects (1974) Diabetes, 23, pp. 161-171Novoa, F.J., Boronat, M., Saavedra, P., Diaz-Cremades, J.M., Varillas, V.F., La Roche, F., Alberiche, M.P., Carrillo, A., Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study (2005) Diabetes Care, 28, pp. 2388-2393Pfeifer, M.A., Halter, J.B., Porte Jr, D.., Insulinsecretion in diabetes mellitus (1981) Am J Med, 70, pp. 579-588Ward, W.K., Bolgiano, D.C., McKnight, B., Diminished-cell secretory capacity in patients with non-insulin dependent diabetes mellitus (1984) J Clin Invest, 74, pp. 1318-1328Byrne, M.M., Sturis, J., Sobel, R.J., Elevated plasma glucose 2h posthallenge predicts defects in β-cell function (1996) Am J Physiol, 270, pp. E572-E579Bergman, R.N., Phillips, L.S., Cobelli, C., Physiological evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose (1981) J Clin Invest, 68, pp. 1456-1467Havel, J.P., Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein and adiponectin (2002) Curr Opin Lipidol, 13, pp. 51-59Rajala, M.W., Scherer, P.E., Minireview: the adipocyte: at the crossroads of energy homeostasis, inflamation and atherosclerosis (2003) Endocrinology, 144, pp. 3765-3773Ferrannini, E., Barrett, E.J., Bevilacqua, S., DeFronzo, R.A., Effect of free fatty acids on glucose production and utilization in man (1983) J Clin Invest, 72, pp. 1737-1745Nolan, C.J., Madiraju, M.S.R., Delghingaro-Augusto, V., Peyot, M.L., Prentki, M., Fatty Acid Signaling in the ß Cell and Insulin Secretion (2006) Diabetes, 55 (SUPPL. 2), pp. S16-S23Zhou, Y.P., Grill, V.E., Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets (1995) Diabetes, 44, pp. 394-399Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Bervia, R., Pratipanawart, N., Bajaj, M., Cusi, K., A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes (2003) Diabetes, 52, pp. 2461-2474Roden, M., Price, T.B., Perseghin, G., Mechanism of free fatty acid induced insulin resistance in humans (1996) J Clin Invest, 97, pp. 2859-2865Roden, M., Krssak, M., Stingl et, al., Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans (1999) Diabetes, 48, pp. 385-364Dresner, A., Laurent, D., Marcucci, M., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol3-kinase activity (1999) J Clin Invest, 103, pp. 253-259Krebs, M., Krssab, M., Nonotny, P., Free fatty acids inhibit the glucose-stimulate increase of intramuscular glucose-6-phosphate concentration in humans (2001) J Clin Endocrinol Metab, 86, pp. 2153-2160Schulman, G.I., Cellular mechanisms of insulin resistance (2000) J Clin Invest, 106, pp. 171-176Randle, P.J., Hales, C.N., Garland, P.B., Newsholme, E.A., The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus (1963) Lancet, 1, pp. 758-789Garvey, W.T., Birnbaum, M., Cellular insulin action and insulin resistance (1993) Clin Endocrinol Metab, 7 (4), pp. 785-873. , Ed: Ferrannini EYu, C., Chen, Y., Cline, G.W., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 [IRS-1] associated phosphatidylinositol 3-kinase activity in muscle (2002) J Biol Chem, 277, pp. 50230-50236Ellis, B.A., Poynten, A., Lowy, A.J., Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle (2000) Am J Physiol, 279, pp. E554-E560Dresner, A., Laurent, D., Marcucci, M., Griffin, M.E., Dufour, S., Cline, G.W., Slezak, L.A., Shulman, G.I., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity (1999) The Journal Clin Invest, 103, pp. 253-259White, M.F., Insulin signaling in health and disease (2003) Science, 302 (5651), pp. 1710-1711Nguyen, M.T., Satoh, H., Favelyukis, S., Babendure, J.L., Imamura, T., Sbodio, J.I., Zalevsky, J., Olefsky, J.M., JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes (2005) J Biol Chem, 280, pp. 35361-35371Gremlich, S., Bonny, C., Waeber, G., Thorens, B., Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels (1997) J Biol Chem, 272, pp. 30261-30269Robertson, R.P., Harmon, J., Tran, P.O., Poitout, V., β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes (2004) Diabetes, 53 (SUPPL. 1), pp. S119-S124Leahy, J.L., Cooper, H.E., Deal, D.A., Weir, G.C., Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions (1986) J. Clin. Invest, 77, pp. 908-991Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., Colette, C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes (2006) JAMA, 295, pp. 1681-1687Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H.I., Spinas, G.A., Kaiser, N., Donath, M.Y., Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets (2002) J Clin Invest, 110, pp. 851-860Robertson, R.P., Zhang, H.J., Pyzdrowski, K.L., Walseth, T.F., Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations (1992) J. Clin. Invest, 90, pp. 320-325Dubois, M., Vacher, P., Roger, B., Huyghe, D., Vandewalle, B., Kerr-Conte, J., Pattou, F., Lang, J., Glucotoxicity Inhibits Late Steps of Insulin Exocytosis (2007) Endocrinology, 148, pp. 1605-1614Tajiri, Y., Moller, C., Grill, V., Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function (1997) Endocrinology, 138, pp. 273-280Spinas, G.A., Palmer, J.P., Mandrup-Poulsen, T., Andersen, H., Nielsen, J.H., Nerup, J., The bimodal effect of interleukin 1 on rat pancreatic β-cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration (1988) Acta Endocrinol (Copenh), 119, pp. 307-311Böni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J.A., Kerr-Conte, J., Pattou, F., Donath, M.Y., Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation (2008) J Clin Endocrinol Metab, 93 (10), pp. 4065-4074Maedler, K., Schulthess, F.T., Bielman, C., Berney, T., Bonny, C., Prentki, M., Donath, M.Y., Roduit, R., Glucose and leptin induce apoptosis in human β-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases (2008) The FASEB Journal, 22, p. 1905Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia (2001) J Clin Endocrinol Metab, 86 (5), pp. 1930-1935Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E., Rossetti, L., Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 (2001) The Journal of Clinical Investigation, 108 (12), pp. 1875-1881Fruebis, J., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice (2001) Proc Natl Acad Sci, 98, pp. 2005-2010Abbasi, F., Chu, J.W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G.M., Reaven, P.D., Discrimination between obesity and insulin resistance in the relationship with adiponectin (2004) Diabetes, 53, pp. 585-590Kharroubi, I., Rasschaert, J., Eizirik, D.L., Cnop, M., Expression of adiponectin receptors in pancreatic b cells (2003) Biochemical and Biophysical Research Communications, 312, pp. 1118-1122Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., Eckel, J., Adiponectin counteracts cytokine-and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1 (2004) Diabetologia, 47, pp. 249-258Staiger, K., Stefan, N., Staiger, H., Brendel, H.D., Brandhorst, D., Bretzel, R.G., Machicao, F., Häring, H.U., Adiponectin Is Functionally Active in Human Islets but Does Not Affect Insulin Secretory Function or β-Cell Lipoapoptosis (2005) J Clin Endocrinol Metab, 90, pp. 6707-6713Kern, P.A., Ranganathan, S., Li, C., Wood, L., Ranganathan, G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance (2001) Am J Physiol Endocrinol Metab, 280 (5), pp. E745-51Liu, L.S., Spelleken, M., Rohrig, K., Hauner, H., Eckel, J., Tumor Necrosis factor alpha acutely inhibits insulin signalling in human adipocytes: implications of the p80 tumor necrosis factor receptor (1998) Diabetes, 47 (4), pp. 515-522Hotamisligil, G.S., Spiegelman, B.M., Tumor necrosis factor alpha: a key component of the obesity-diabetes link (1994) Diabetes, 43 (11), pp. 1271-1278Kanety, H., Feinstein, R., Papa, M.Z., Hemi, R., Karasik, A., Tumor necrosis factor alpha induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1 (1995) The Journal of Biological Chemistry, 270 (40), pp. 23780-23784Hauner, H., Petruschke, T., Russ, M., Rohrig, K., Eckel, J., Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture (1995) Diabetologia, 38, pp. 764-771Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C., Greenberg, A.S., Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP (2002) Diabetes, 51, pp. 2929-2935Maeda, N., Shimomura, I., Kishida, K., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 (2002) Nat Med, 8, pp. 731-737Wang, B., Jenkins, J.R., Trayhurn, P., Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha (2005) Am J Physiol Endocrin

Predictability Of Quantification Of Beta-trace Protein For Diagnosis Of Cerebrospinal Fluid Leak: Cutoff Determination In Nasal Fluids With Two Control Groups

Background: Cerebrospinal fluid (CSF) leak of the anterior skull base is an abnormal communication between the subarachnoid space and the nasal cavity or the paranasal sinus. Its presence increases the incidence of complications, as meningitis, with risk of sequelae. The early and correct diagnosis of the CSF leaks is important to perform surgical treatment as soon as possible. The CSF detection in nasal fluids could be made through the beta2-transferrin (beta2Tr) immunoelectrophoretic test, an expensive and cumbersome immunologic test, not available to the majority of the Brazilian hospitals. Recently, the detection of beta-trace protein (betaTP) for identification of CSF leaks has been described. The literature suggests there may be similar sensitivity and specificity to tests of beta2Tr, because betaTP is also a specific brain protein and it is present in CSF in high concentrations. The majority of Brazilian hospitals have the nephelometric equipment for betaTP detection. This study was designed to determine threshold values for betaTP concentrations in nasal cavity secretions as a predictor of CFS leak. Methods: Nasal secretions were collected from patients with suspicion of CSF leak and from healthy volunteers. Pure CSF samples were used. A nephelometric assay was used to determine the betaTP concentration in samples. Results: Values between 0.244 and 0.496 mg/L were determined for the cutoff. Conclusion: Beta-trace concentrations above 0.496 mg/L are highly suggestive of the presence of CSF in examined nasal secretion. Positive predictive value and negative predictive value were 100%. BetaTP nephelometric test can predict the side of the CSF leak. Copyright © 2009, OceanSide Publications, Inc.236585590Har-El, G., What is "spontaneous" cerebrospinal fluid rhinorrhea? Classification of cerebrospinal fluid leaks (1999) Ann Otol Rhinol Laryngol, 108, pp. 323-326Meco, C., Oberascher, G., Comprehensive algorithm for skull base dural lesion and cerebrospinal fluid fistula diagnosis (2004) Laryngoscope, 114, pp. 991-999Choi, D., Spann, R., Traumatic cerebrospinal fluid leakage: Risk factors and the use of prophylactic antibiotics (1996) Br J Neurosurg, 10, pp. 571-575Crawford, C., Kennedy, N., Weir, W.R., Cerebrospinal fluid rhinorrhea and Haemophilus influenzae meningitis 37 years after a head injury (1994) J Infect, 28, pp. 93-97Brodie, H.A., Prophylactic antibiotics for posttraumatic cerebrospinal fluid fistulae: A meta-analysis (1997) Arch Otolaryngol Head Neck Surg, 123, pp. 749-752Chan, D.T.M., Poon, W.S., Ip, C.P., How useful is glucose detection in diagnosing cerebrospinal fluid leak? The rational use of CT and beta-2 transferrin assay in detection of cerebrospinal fluid fistula (2004) Asian J Surg, 27, pp. 39-42Baker, E.H., Wood, D.M., Brennan, A.L., New insights into the glucose oxidase stick test for cerebrospinal fluid rhinorrhoea (2005) Emerg Med J, 22, pp. 556-557Freek, W.C., Roelandse, N., van der Zwart, J.H.D., Detection of CSF leakage by isoelectric focusing on polyacrylamide gel, direct immunofixation of transferrins, and silver staining (1998) Clin Chem, 44, pp. 351-353Watanabe, K., Urade, Y., Mäder, M., Identification of β-trace as prostaglandin D synthase (1994) Biochem Biophys Res Commun, 203, pp. 1110-1116Urade, Y., Kathama, K., Oshishi, J., Dominant expression of m-RNA for prostaglandin D-synthetase in leptomeninges, choroids plexus and oligodendrocytes of the adult rat brain (1993) Proc Natl Acad Sci USA, 90, pp. 9070-9074Reiber, H., Dynamics of brain-derived proteins in cerebrospinal fluid (2001) Clin Chim Acta, 20, pp. 173-186Felgenhauer, K., Schadlich, H.J., Nekic, M., β-trace protein as marker for cerebrospinal fluid fistula (1987) Klin Wochenschr, 65, pp. 764-768Meco, C., Berascher, G., Arrer, E., β-Trace protein test: New guidelines for the reliable diagnosis of cerebrospinal fluid fistula (2003) Otolaryngol Head Neck Surg, 129, pp. 508-517Bachmann-Harildstad, G., Diagnostic values of beta-2 transferrin and beta-trace protein as markers for cerebrospinal fluid fistula (2008) Rhinology, 46, pp. 82-85Reiber, H., Walther, K., Althaus, H., Beta-trace protein as sensitive marker for CSF rhinorhea and CSF otorhea (2003) Acta Neurol Scand, 108, pp. 359-362Kleine, T.O., Damm, T., Althaus, H., Quantification of β-trace protein and detection of transferrin isoforms in mixtures of cerebrospinal fluid and blood serum as models of rhinorrhea and otorrhea diagnosis (2000) Fresenius J Anal Chem, 366, pp. 382-386Schlosser, R.J., Bolger, W.E., Endoscopic management of cerebrospinal fluid rhinorrhea (2006) Otolaryngol Clin North Am, 39, pp. 523-538Mattox, D.E., Kennedy, D.W., Endoscopic management of cerebrospinal fluid leaks and cephaloceles (1990) Laryngoscope, 100, pp. 857-862Petereit, H.F., Bachmann, G., Nekic, M., A new nephelometric assay for β-trace protein (prostaglandin D synthase) as an indicator of liquorrhoea (2001) J Neurol Neurosurg Psychiatry, 71, pp. 347-351Schnabel, C., Di Martino, E., Gilsbach, J.M., Comparison of β2-transferrin and β-trace protein for detection of cerebrospinal fluid in nasal and ear fluids (2004) Clin Chem, 50, pp. 661-663Risch, L., Lisec, I., Jutzi, M., Rapid, accurate and non-invasive detection of cerebrospinal fluid leakage using combined determination of β-trace protein in secretion and serum (2005) Clin Chim Acta, 351, pp. 169-176Melegos, D.N., Diamandis, E.P., Oda, H., Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids (1996) Clin Chem, 42, pp. 1984-1991Arrer, E., Meco, C., Oberascher, G., β-Trace protein as a marker for cerebrospinal fluid rhinorrhea (2002) Clin Chem, 48, pp. 939-941Melegos, D.N., Grass, L., Pierratos, A., Diamandis, E.P., Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure (1999) Urology, 53, pp. 32-37Tumani, H., Reiber, H., Nau, R., Felgenhauer β-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis (1998) Neurosci Lett, 242, pp. 5-8Meco, C., Arrer, E., Oberascher, G., Efficacy of cerebrospinal fluid fistula repair: Sensitive quality control using the beta-trace protein test (2007) Am J Rhinol, 21, pp. 729-736Zuckerman, J.D., DelGaudio, J.M., Utility of preoperative highresolution CT and intraoperative image guidance in identification of cerebrospinal fluid leaks for endoscopic repair (2008) Am J Rhinol, 22, pp. 151-154Schick, B., Ibing, R., Brors, D., Draf, W., Long- term study of endonasal duraplasty and review of the literature (2001) Ann Otol Rhinol Laryngol, 110, pp. 142-14

The Evaluation Of Antigenic Preparations Of Strongyloides Stercoralis For The Immunodiagnosis Of Strongyloidiasis [avaliação De Preparações Antigênicas De Strongyloides Stercoralis Para O Imunodiagnóstico Da Estrongiloidíase.]

Aqueous-soluble (AS) antigens from larvae of Strongyloides stercoralis, extracted with phosphate-buffered saline, are traditionally used for serodiagnosis of strongyloidiasis. To identify sources of antigens for use in serodiagnosis, residual particulates from parasite larvae after aqueous extraction were solubilized with Tris-buffered 8M urea, yielding a urea-soluble (US) antigen fraction. Both AS and US antigens from S. stercoralis were evaluated by an enzyme-linked immunosorbent assay. No significative differences were observed between AS and US antigens from the parasite regarding specific antigenic activity and cross-reactivity. Immunoassays are highly dependent on the antigen for sensitivity and specificity. Crude extracts from S. stercoralis should be further studied, mainly in relation to antigenic fractions which could provide even more sensitive and specific results. Studies of fractionation of S. stercoralis must take into account the antigen yield of both the crude extract and fractions, since larvae of parasite are normally difficult to obtain. Considering this aspect, the results from this study are very useful, since the extraction with urea substantially increased the amounts of antigenic materials normally obtained with the classical aqueous extraction.262838